The goal of this clinical trial is to assess effect of Intravenous immunoglobulins
(antibodies) as compared to Placebo, on pain intensity in patients from 18-65 years with
painful sensory neuropathy without a known cause. Effect of the treatment will be recorded by
the patient in a digital diary.
Phase:
Phase 4
Details
Lead Sponsor:
Sorlandet Hospital HF
Collaborators:
Oslo University Hospital University Hospital of North Norway University Hospital of Saint-Etienne